• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAXTER HEALTHCARE CORPORATION PRISMAFLEX TPE; DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAXTER HEALTHCARE CORPORATION PRISMAFLEX TPE; DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM Back to Search Results
Catalog Number 114093
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Low Blood Pressure/ Hypotension (1914); Muscle Weakness/Atrophy (1967); Nausea (1970); Vomiting (2144); Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available (4581)
Date of Event 03/16/2022
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Should additional relevant information become available, a supplemental report will be submitted.
 
Event or Problem Description
It was reported that within the first few minutes of therapeutic plasma exchange with a prismaflex tpe2000, a blood leak detector alarm was triggered and an internal blood leak was identified.Visible blood tinged effluent was observed in the effluent line and the drain bag.Visible blood was also observed on the outside of the filter semi-permeable membrane fibers.Treatment was stopped without blood return.A total of 125ml of blood was lost.The patient was stable and the vital signs were normal.Within twenty (20) minutes of starting a new tpe treatment the patient became pale and presented with weakness, nausea and vomiting.The blood pressure reading was 84/43 mmhg.The patient was treated with an unspecified amount of saline.The patient reported they were not feeling well and treatment was interrupted with blood return and another 30 ml saline was provided.The patient 's condition subsequently improved, and the blood pressure increased to 110/60 mmhg.Tpe treatment was suspended for the day.No additional information is available.
 
Additional Manufacturer Narrative
H10: the actual device was received for investigation.A pressure test was performed, no bubbling, no leak or entry of air was observed.The reported condition was not verified.A batch review was conducted and there were no deviations found related to this reported condition during the manufacture of this lot.Should additional relevant information become available, a supplemental report will be submitted.
 
Additional Manufacturer Narrative
Additional information added to b1, h1 and h10.H10: based on additional information from device evaluation, and review of clinical circumstances surrounding the event, it is possible that the event of patient symptoms requiring medical intervention was associated with the previous blood loss in combination with underlying medical condition and applied treatment parameters when restarting the tpe treatment, therefore, it is unlikely that the prismaflex tpe 2000 caused or contributed to the serious event of patient symptoms.Based on additional information received, prismaflex tpe 2000 was determined not to be a factor in the reported adverse event.Should additional relevant information become available, a supplemental report will be submitted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PRISMAFLEX TPE
Common Device Name
DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM
Manufacturer (Section D)
BAXTER HEALTHCARE CORPORATION
deerfield IL
Manufacturer (Section G)
BAXTER HEALTHCARE - MEYZIEU
7, av lionel terray, b.p. 126
meyzieu cedex rhone 69883
FR   69883
Manufacturer Contact
25212 w. illinois route 120
round lake, IL 
2242702068
MDR Report Key13970927
Report Number8010182-2022-00085
Device Sequence Number4524161
Product Code KDI
UDI-Device Identifier07332414111038
UDI-Public(01)07332414111038
Combination Product (Y/N)N
Initial Reporter StateTX
Initial Reporter CountryUS
PMA/510(K) Number
PMA P830063
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Nurse
Type of Report Initial,Followup,Followup
Report Date (Section B) 07/14/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date03/31/2024
Device Catalogue Number114093
Device Lot Number21D1404
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 03/14/2022
Supplement Date Received by Manufacturer04/25/2022
07/13/2022
Initial Report FDA Received Date03/31/2022
Supplement Report FDA Received Date04/26/2022
07/14/2022
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
NI.
Outcome Attributed to Adverse Event Other;
Patient Age12 YR
Patient SexMale
-
-